Development of an Experimental Model of Cardiac Failure Combined with Type I Diabetes Mellitus

被引:0
|
作者
S. A. Afanasiev
D. S. Kondratyeva
S. V. Popov
机构
[1] Siberian Division of the Russian Academy of Medical Sciences,Institute of Cardiology, Tomsk Research Center
来源
Bulletin of Experimental Biology and Medicine | 2012年 / 153卷
关键词
heart failure; type 1 diabetes mellitus; streptozotocin; coronary occlusion;
D O I
暂无
中图分类号
学科分类号
摘要
The doses and mode of streptozotocin injection for modeling heart failure combined with type 1 diabetes mellitus have been determined. Combined disease was induced in animals by injecting the selected streptozotocin dose (60 mg/kg intraperitoneally) at the stage of heart failure formation (2 weeks after coronary occlusion). This protocol of experiment led to development of hyperglycemia, body weight loss, and formation of myocardial cicatrix and hypertrophy corresponding to signs of heart failure paralleled by diabetes mellitus.
引用
收藏
页码:530 / 532
页数:2
相关论文
共 50 条
  • [31] COMBINED KIDNEY AND PANCREAS TRANSPLANTATION IN DIABETES-MELLITUS TYPE-I - REPLY
    ROTHMUND, M
    GREGER, B
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (16) : 587 - 588
  • [32] Type 2 diabetes mellitus and heart failure
    Choy, Christine K.
    Rodgers, Jo E.
    Nappi, Jean M.
    Haines, Stuart T.
    PHARMACOTHERAPY, 2008, 28 (02): : 170 - 192
  • [33] β-cell failure in type 2 diabetes mellitus
    Cristina Lencioni
    Roberto Lupi
    Stefano Del Prato
    Current Diabetes Reports, 2008, 8 : 179 - 184
  • [34] β-Cell Failure in Type 2 Diabetes Mellitus
    Lencioni, Cristina
    Lupi, Roberto
    Del Prato, Stefano
    CURRENT DIABETES REPORTS, 2008, 8 (03) : 179 - 184
  • [35] A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus
    Williams, Brent A.
    Geba, Daniela
    Cordova, Jeanine M.
    Shetty, Sharash S.
    CLINICAL CARDIOLOGY, 2020, 43 (03) : 275 - 283
  • [36] Cardiac rehabilitation in patients with heart failure and diabetes mellitus
    Florina, Fringu
    Bogdan, Caloian
    Diana, Gurzau
    Horatiu, Comsa
    Gusetu, Gabriel
    Zdrenghea, Dumitru
    Pop, Dana
    BALNEO RESEARCH JOURNAL, 2018, 9 (02) : 73 - 75
  • [37] Vitamin C attenuation of the development of type I diabetes mellitus by interferon-α
    Al-Zuhair, H
    Mohamed, HE
    PHARMACOLOGICAL RESEARCH, 1998, 38 (01) : 59 - 64
  • [38] Teplizumab for Treatment of Type I Diabetes Mellitus
    Skelley, Jessica W.
    Elmore, Lindsey K.
    Kyle, Jeffrey A.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (10) : 1405 - 1412
  • [39] Canagliflozin use in Type I diabetes mellitus
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2017, 129 (03) : 336 - 339
  • [40] Breast manifestations of type I diabetes mellitus
    Nasser, Haydar A.
    Assaf, Sarah
    Aouad, Ghadir
    Mouawad, Yara
    Elamely, Sabah
    BREAST JOURNAL, 2020, 26 (10): : 2079 - 2080